المصدر: Tetrahedron

مصطلحات الفهرس: Acyl hydrazines, Cyclization, Isatin, Pfitzinger, pyrrolo[3,4-c]quinoline, article

URL: info:eu-repo/grantAgreement/MESTD/inst-2020/200122/RS
info:eu-repo/grantAgreement/MESTD/inst-2020/200168/RS

المصدر: Bioorganic & medicinal chemistry, 18 (7

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Antineoplastic Agents -- chemical synthesis, Antineoplastic Agents -- pharmacology, Apoptosis -- drug effects, Cell Line, Tumor, Coumaric Acids -- chemistry, Crystallography, X-Ray, Drug Screening Assays, Antitumor, Humans, Hydrazines -- chemical synthesis, Hydrazines -- pharmacology, Magnetic Resonance Spectroscopy, Microscopy, Video, Phthalazines -- chemical synthesis, Phthalazines -- pharmacology, Spectrophotometry, Infrared, Structure-Activity Relationship, Anticancer, Apoptosis-resistant, Cinnamic acid, Cyclopropyl backbone, Cytostatic activity, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/70174/1/Elsevier_47291.pdfTest
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/70174Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest

المصدر: Bioorganic & medicinal chemistry, 18 (7

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Antineoplastic Agents -- chemical synthesis, Antineoplastic Agents -- pharmacology, Apoptosis -- drug effects, Cell Line, Tumor, Coumaric Acids -- chemistry, Crystallography, X-Ray, Drug Screening Assays, Antitumor, Humans, Hydrazines -- chemical synthesis, Hydrazines -- pharmacology, Magnetic Resonance Spectroscopy, Microscopy, Video, Phthalazines -- chemical synthesis, Phthalazines -- pharmacology, Spectrophotometry, Infrared, Structure-Activity Relationship, Anticancer, Apoptosis-resistant, Cinnamic acid, Cyclopropyl backbone, Cytostatic activity, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/70174/1/Elsevier_47291.pdfTest
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/70174Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest

المصدر: Revista Científica, ISSN 2344-8350, Vol. 45, Nº. 3, 2022 (Ejemplar dedicado a: september-december), pags. 315-327

مصطلحات الفهرس: Pirazolinas, Síntesis, Chalconas, Ciclocondensación, Hidrazinas, Pyrazolines, Synthesis, Chalcones, Cyclocondensation, Hydrazines, text (article)

URL: https://dialnet.unirioja.es/servlet/oaiart?codigo=8901300Test

المصدر: Revista Científica, ISSN 2344-8350, Vol. 45, Nº. 3, 2022 (Ejemplar dedicado a: september-december), pags. 315-327

مصطلحات الفهرس: Pirazolinas, Síntesis, Chalconas, Ciclocondensación, Hidrazinas, Pyrazolines, Synthesis, Chalcones, Cyclocondensation, Hydrazines, text (article)

URL: https://dialnet.unirioja.es/servlet/oaiart?codigo=8901300Test

المصدر: Emdal , K B , Palacio-Escat , N , Wigerup , C , Eguchi , A , Nilsson , H , Bekker-Jensen , D B , Rönnstrand , L , Kazi , J U , Puissant , A , Itzykson , R , Saez-Rodriguez , J , Masson , K , Blume-Jensen , P & Olsen , J V 2022 , ' Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance ' , Cell Reports , vol. 40 , no. 6 , 111177 .

مصطلحات الفهرس: Apoptosis, Cell Line, Tumor, Humans, Hydrazines, Leukemia, Myeloid, Acute/drug therapy, Proteome/metabolism, Proto-Oncogene Proteins c-akt/metabolism, Triazoles, Tumor Suppressor Protein p53/metabolism, article

URL: https://curis.ku.dk/portal/da/publications/phosphoproteomics-of-primary-aml-patient-samples-reveals-rationale-for-akt-combination-therapy-and-p53-context-to-overcome-selinexor-resistanceTest(82de543d-0dc2-40e4-a54d-5470c6442433).html
https://doi.org/10.1016/j.celrep.2022.111177Test
https://curis.ku.dk/ws/files/319798801/PIIS2211124722009901.pdfTest

المصدر: Clinical lymphoma, myeloma & leukemia, Vol. 22, no.1, p. 24-33 (2022)

مصطلحات الفهرس: Adult, Aged, Aged, 80 and over, Female, Humans, Hydrazines, Lymphoma, Large B-Cell, Diffuse, Male, Middle Aged, Treatment Outcome, Triazoles, DLBCL subtypes, De novo and transformed DLBCL, Relapsed/refractory DLBCL, Salvage therapy, Treatment response, XPO1, info:eu-repo/semantics/article

URL: http://hdl.handle.net/2078.1/261893Test

المصدر: Clinical lymphoma, myeloma & leukemia, Vol. 22, no.7, p. 483-494 (2022)

مصطلحات الفهرس: Humans, Hydrazines, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Triazoles, Exportin-1, Monotherapy, Pretreated, Refractory, Relapsed, SINE compounds, XPO1, info:eu-repo/semantics/article

URL: http://hdl.handle.net/2078.1/263505Test

المصدر: Leukemia, Vol. 36, no.9, p. 2189-2195 (2022)

مصطلحات الفهرس: Active Transport, Cell Nucleus, Aged, Antineoplastic Combined Chemotherapy Protocols, Cytarabine, Humans, Hydrazines, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Triazoles, info:eu-repo/semantics/article

URL: http://hdl.handle.net/2078.1/270877Test

المصدر: Emdal , K B , Palacio-Escat , N , Wigerup , C , Eguchi , A , Nilsson , H , Bekker-Jensen , D B , Rönnstrand , L , Kazi , J U , Puissant , A , Itzykson , R , Saez-Rodriguez , J , Masson , K , Blume-Jensen , P & Olsen , J V 2022 , ' Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance ' , Cell Reports , vol. 40 , no. 6 , 111177 .

مصطلحات الفهرس: Apoptosis, Cell Line, Tumor, Humans, Hydrazines, Leukemia, Myeloid, Acute/drug therapy, Proteome/metabolism, Proto-Oncogene Proteins c-akt/metabolism, Triazoles, Tumor Suppressor Protein p53/metabolism, article

URL: https://curis.ku.dk/portal/da/publications/phosphoproteomics-of-primary-aml-patient-samples-reveals-rationale-for-akt-combination-therapy-and-p53-context-to-overcome-selinexor-resistanceTest(82de543d-0dc2-40e4-a54d-5470c6442433).html
https://doi.org/10.1016/j.celrep.2022.111177Test
https://curis.ku.dk/ws/files/319798801/PIIS2211124722009901.pdfTest